Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer

Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: Redefining ‘optimal’ residual disease

(2012) Suk-Joon Chang et al.   GYNECOLOGIC ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease

(2010) Pauline Wimberger et al.   ANNALS OF SURGICAL ONCOLOGY

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

(2010) Michele Peiretti et al.   GYNECOLOGIC ONCOLOGY

Maximal cytoreductive effort in epithelial ovarian cancer surgery

(2010) Karin K. Shih et al.   Journal of Gynecologic Oncology

Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian Cancer

(2009) S. Kommoss et al.   ANNALS OF SURGICAL ONCOLOGY

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

(2009) Andreas du Bois et al.   CANCER

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

(2009) Dennis S. Chi et al.   GYNECOLOGIC ONCOLOGY

Transverse colectomy in ovarian cancer surgical cytoreduction: Operative technique and clinical outcome

(2008) Robert E. Bristow et al.   GYNECOLOGIC ONCOLOGY

Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

(2007) William E. Winter et al.   JOURNAL OF CLINICAL ONCOLOGY